243 related articles for article (PubMed ID: 35096509)
1. SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses.
Grupper A; Katchman H
Curr Transplant Rep; 2022; 9(1):35-47. PubMed ID: 35096509
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know.
Giannella M; Pierrotti LC; Helanterä I; Manuel O
Transpl Int; 2021 Oct; 34(10):1776-1788. PubMed ID: 34450686
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis.
Manothummetha K; Chuleerarux N; Sanguankeo A; Kates OS; Hirankarn N; Thongkam A; Dioverti-Prono MV; Torvorapanit P; Langsiri N; Worasilchai N; Moonla C; Plongla R; Garneau WM; Chindamporn A; Nissaisorakarn P; Thaniyavarn T; Nematollahi S; Permpalung N
JAMA Netw Open; 2022 Apr; 5(4):e226822. PubMed ID: 35412626
[TBL] [Abstract][Full Text] [Related]
4. Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age.
Tanner R; Starr N; Chan G; Dempsey E; Heffernan E; Newman E; O'Neill J; Hannan MM; Lynch B; Joyce E
J Heart Lung Transplant; 2022 Apr; 41(4):492-500. PubMed ID: 35090809
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study.
Kabbani D; Yotis DM; Ferreira VH; Shalhoub S; Belga S; Tyagi V; Ierullo M; Kulasingam V; Hébert MJ; West L; Delisle JS; Racine N; De Serres SA; Cardinal H; Dieudé M; Humar A; Kumar D
Open Forum Infect Dis; 2023 May; 10(5):ofad200. PubMed ID: 37213422
[TBL] [Abstract][Full Text] [Related]
6. Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety.
Svorcova M; Novysedlak R; Lischke R; Vachtenheim J; Strizova Z
Front Immunol; 2022; 13():906225. PubMed ID: 35720376
[TBL] [Abstract][Full Text] [Related]
7. Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls.
Hamm SR; Møller DL; Pérez-Alós L; Hansen CB; Pries-Heje MM; Heftdal LD; Hasselbalch RB; Fogh K; Madsen JR; Almagro Armenteros JJ; Knudsen AD; Poulsen JR; Frikke-Schmidt R; Hilsted LM; Sørensen E; Ostrowski SR; Harboe ZB; Perch M; Sørensen SS; Rasmussen A; Bundgaard H; Garred P; Iversen K; Nielsen SD
Front Immunol; 2022; 13():832501. PubMed ID: 35281023
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients.
Peghin M; Graziano E; Grossi PA
Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146506
[TBL] [Abstract][Full Text] [Related]
9. Update on COVID-19 vaccination in pediatric solid organ transplant recipients.
Dulek DE; Ardura MI; Green M; Michaels MG; Chaudhuri A; Vasquez L; Danziger-Isakov L; Posfay-Barbe KM; McCulloch MI; L'Huillier AG; Benden C
Pediatr Transplant; 2022 Aug; 26(5):e14235. PubMed ID: 35060251
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and solid organ transplantation: Finding the right balance.
Opsomer R; Kuypers D
Transplant Rev (Orlando); 2022 Jul; 36(3):100710. PubMed ID: 35809422
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients.
Sakuraba A; Luna A; Micic D
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016444
[TBL] [Abstract][Full Text] [Related]
12. Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies.
Candel FJ; Salavert M; Lorite Mingot D; Manzano Crespo M; Pérez Portero P; Cuervo Pinto R
Rev Esp Quimioter; 2023 Aug; 36(4):380-391. PubMed ID: 37089055
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis.
Chen X; Luo D; Mei B; Du J; Liu X; Xie H; Liu L; Su S; Mai G
Clin Microbiol Infect; 2023 Apr; 29(4):441-456. PubMed ID: 36509376
[TBL] [Abstract][Full Text] [Related]
14. Serological Responses after a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis.
Mu Y; Wu H; Jiang Z; Liu K; Xue X; Zhang W; Chen Z
Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514946
[TBL] [Abstract][Full Text] [Related]
15. Head-to-Head Comparison of Response Rates to the Two mRNA SARS-CοV-2 Vaccines in a Large Cohort of Solid Organ Transplant (SOT) Recipients.
Marinaki S; Degiannis D; Roussos S; Xagas E; Tsoutsoura P; Adamopoulos S; Sypsa V; Chaidaroglou A; Pavlopoulou ID; Hatzakis A; Boletis IN
Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214649
[TBL] [Abstract][Full Text] [Related]
16. Humoral Immunogenicity to SARS-CoV-2 Vaccination in Liver Transplant Recipients: A Systematic Review and Meta-Analysis.
Yoo JJ; Yon DK; Lee SW; Shin JI; Kim BK
Int J Biol Sci; 2022; 18(15):5849-5857. PubMed ID: 36263175
[TBL] [Abstract][Full Text] [Related]
17. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
[TBL] [Abstract][Full Text] [Related]
18. Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.
Erol Ç; Yanık Yalçın T; Sarı N; Bayraktar N; Ayvazoğlu Soy E; Yavuz Çolak M; Azap Ö; Arslan H; Haberal M
Exp Clin Transplant; 2021 Dec; 19(12):1334-1340. PubMed ID: 34951350
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of early vaccination with live attenuated measles vaccine for hematopoietic stem cell transplant recipients and solid organ transplant recipients.
Groeneweg L; Loeffen YGT; Versluys AB; Wolfs TFW
Vaccine; 2021 Jun; 39(25):3338-3345. PubMed ID: 33992440
[TBL] [Abstract][Full Text] [Related]
20. Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients.
Stock PG; Henrich TJ; Segev DL; Werbel WA
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34143755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
